Aquabounty Technologies Inc (OQ:AQB)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 233 Ayer Road Suite 4, Suite 4
HARVARD MA 01451
Tel: N/A
Website: https://aquabounty.com
IR: See website
<
Key People
Sylvia A. Wulf
Chairman of the Board, Chief Executive Officer
David F. Melbourne
President
David A. Frank
Chief Financial Officer, Treasurer
Angela M. Olsen
General Counsel, Corporate Secretary
   
Business Overview
AquaBounty Technologies, Inc. is a land-based aquaculture company. The Company provides fresh Atlantic salmon to nearby markets by raising its fish in monitored land-based fish farms. The Company's land-based Recirculating Aquaculture System (RAS) farms are designed to prevent disease and include multiple levels of fish containment to protect wild fish populations. RAS facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens, which might enter the system. Its GE Atlantic salmon is based upon salmon genetics and grows to harvest size faster than conventional Atlantic salmon. The Company is vertically integrated and maintains its own broodstock hatchery, which produces the eggs that it grows-out to harvest size in its production farms. It operates two salmon farms: a 1,200 metric ton production grow-out farm in Indiana and a broodstock farm on Prince Edward Island, Canada.
Financial Overview
For the nine months ended 30 September 2023, Aquabounty Technologies Inc revenues decreased 29% to $1.9M. Net loss increased 19% to $19.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects General and administrative increase of 12% to $8.4M (expense), Other Income (expense), Net decrease of 82% to $62K (income).
Employees: 100 as of Dec 31, 2022
Reporting Currency: U.S. Dollars
Enterprise value: N/A
Annual revenue (TTM): $2.37M as of Sep 30, 2023
EBITDA (TTM): -$22.98M as of Sep 30, 2023
Net annual income (TTM): -$25.20M as of Sep 30, 2023
Free cash flow (TTM): -$110.37M as of Sep 30, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 3,846,772 as of Nov 6, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.